No Data
No Data
Express News | Chemours Shares Are Trading Higher After the Company Announced It Has Partnered With Several Entities to Launch a Full-scale Product Trial for Data Center Two-phase Immersion Cooling
Chemours Leads Product Trial to Cut Data Center Cooling Energy Use by 90%: Details
Express News | Chemours Joins Forces With NTT Data and Hibiya Engineering, Ltd. for Full-Scale Opteon™ 2P50 Product Trial
Chemours Joins Forces With NTT DATA and Hibiya Engineering, Ltd. For Full-Scale Opteon 2P50 Product Trial
Mizuho Securities Maintains The Chemours(CC.US) With Hold Rating
Barclays Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $19